. . . . . . . "[Here we show that the allosteric AKT inhibitor MK-2206 rapidly and potently antagonizes rDNA transcription in E?-Myc B-cell lymphomas in vivo, and this is associated with a rapid reduction in indicators of disease burden, including spleen weight and the abundance of tumour cells in both the circulation and lymph nodes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:23+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .